| Literature DB >> 30214052 |
Elena Porzio1, Francesca Bettazzi2, Luigi Mandrich1, Immacolata Del Giudice1, Odile F Restaino3, Serena Laschi4, Ferdinando Febbraio1, Valentina De Luca1, Maria G Borzacchiello3, Teresa M Carusone1, Franz Worek5, Antonio Pisanti6, Piero Porcaro6, Chiara Schiraldi3, Mario De Rosa3, Ilaria Palchetti2, Giuseppe Manco7.
Abstract
Pesticides and warfare nerve agents are frequently organophosphates (OPs) or related compounds. Their acute toxicity highlighted more than ever the need to explore applicable strategies for the sensing, decontamination and/or detoxification of these compounds. Herein, we report the use of two different thermostable enzyme families capable to detect and inactivate OPs. In particular, mutants of carboxylesterase-2 from Alicyclobacillus acidocaldarius and of phosphotriesterase-like lactonases from Sulfolobus solfataricus and Sulfolobus acidocaldarius, have been selected and assembled in an optimized format for the development of an electrochemical biosensor and a decontamination formulation, respectively. The features of the developed tools have been tested in an ad-hoc fabricated chamber, to mimic an alarming situation of exposure to a nerve agent. Choosing ethyl-paraoxon as nerve agent simulant, a limit of detection (LOD) of 0.4 nM, after 5 s of exposure time was obtained. Furthermore, an optimized enzymatic formulation was used for a fast and efficient environmental detoxification (>99%) of the nebulized nerve agent simulants in the air and on surfaces. Crucial, large-scale experiments have been possible thanks to production of grams amounts of pure (>90%) enzymes.Entities:
Mesh:
Substances:
Year: 2018 PMID: 30214052 PMCID: PMC6137069 DOI: 10.1038/s41598-018-31751-5
Source DB: PubMed Journal: Sci Rep ISSN: 2045-2322 Impact factor: 4.379
Figure 1Scheme of the assay. The biosensor is obtained by modification of the carbon electrode surface with the enzymatic layer (EST2 mutant, BSA and CMC). Upon the addition of NaAc, the electroactive product (2-naphthol) is oxidized at the electrode and a peak current is recorded in DPV. If a nerve agent is present, the enzyme will be inhibited, and a decrease of the peak current is observed. Sensor array used for developing the biosensing MEP, without and with the plastic wells.
Figure 2Development of the electrochemical biosensing assay. (a) Inhibitory effect of different toxicants on EST2 wt, K42R/K61R and other mutants. For presentation clarity, the effect of POX on the different mutants is also shown in the next panel (b); Different toxicants were diluted to 1 μM in PB containing N-bromosuccinimide (NBS) in a ratio of 1:90, allowing the solution to be incubated at room temperature for 5 min. NBS oxidizes the thio-organophosphorus compounds by generating their respective oxidized analogs, which are more toxic for the enzymes. Percentage (%) of inhibition is reported for each enzyme with each toxicant. All the values are the means of measurements taken from three independent experiments, the error bars representing the standard deviations; (c) The POX dose-response plot, using K42R/K61R mutant electrochemical biosensor. Each value is the mean of measurements taken from five independent experiments, the error bars corresponding to the standard deviations d) Evaluation of the stability of the enzyme based assay during a period of 4 months. The biosensing MEPs were stored at 4 °C. I% measurements were performed using, 0.5 mM NaAc concentration and 5 s POX exposure time, for 1 µM POX. Each value is the mean of measurements taken from three independent measurements, the error bars corresponding to the standard deviations.
Figure 3Demonstrator chamber. The inhibitory effect of POX on the EST2 biosensing platform was evaluated by nebulizing the NAS solution (100 µM POX, 100 µM MPOX, 25 µM MPTON), in the demonstrator chamber (2.30 × 2.30 × 2.80 m, Scheme (a) and Real view (b), by using 2 pumps (MGF1 and 2 for enzyme (E) and NAS (S) respectively) and a control system (PLC and see SI).
Kinetic analyses of thermostable PLLs including SsoPox, its two variants W263F and Sso3Mut and SacPox towards hydrolysis of “live” nerve agents.
| Tabun | n.a. | n.a. | n.a. | 4.12 ± 1.04 × 103 |
| Sarin | n.a. | n.a. | n.a. | 1.66 ± 0.31 × 104 |
| Soman | n.a. | n.a. | n.a. | 2.59 ± 0.67 × 103 |
| Cyclosarin | n.a. | n.a. | n.a. | 4.58 ± 0.05 × 103 |
| (+)-Cyclosarin | 0.0292 ± 0.0014a | 0.1042 ± 0.0025a | 0.0297 ± 0.0009a | n.a. |
| (−)-Cyclosarin | 0.0218 ± 0.0011a | 0.0309 ± 0.0012a | 0.132 ± 0.0039a | n.a. |
| VX | n.a. | n.a. | n.a. | n.d. |
aData taken from Merone et al.[27]. n.a.: not analyzed; n.d.: not detected. Values are means ± the SD of measurements taken from three experiments.
Residual concentration of NAS extracted from the four surfaces placed on the three walls of the box after nebulization of ENZYMIX3.
| Samples | MPOX (μmol/cm2) | MPTON (μmol/cm2) | POX (μmol/cm2) | |||
|---|---|---|---|---|---|---|
| Glass 1 | <1*10−5 | nd | 2.6*10−5 | 1.5*10−6 | <1*10−5 | 6.0*10−5 |
| Glass 2 | <1*10−5 | nd | <1*10−5 | nd | <1*10−5 | 4.95*10−4 |
| Glass 3 | <1*10−5 | nd | <1*10−5 | nd | <1*10−5 | 9.86*10−4 |
| Aluminum 1 | <1*10−5 | nd | <1*10−5 | 4.35*10−5 | <1*10−5 | 5.785*10−4 |
| Aluminum 2 | <1*10−5 | nd | <1*10−5 | 1.15*10−5 | <1*10−5 | 3.54*10−4 |
| Aluminum 3 | <1*10−5 | nd | <1*10−5 | 7.5*10−6 | <1*10−5 | 4.485*10−4 |
| Linoleum 1 | <1*10−5 | 2.23*10−4 | 2.0*10−5 | 2.5*10−4 | <1*10−5 | 5.69*10−4 |
| Linoleum 2 | <1*10−5 | 1.95*10−4 | <1*10−5 | 9.0*10−6 | <1*10−5 | 1.00*10−3 |
| Linoleum 3 | <1*10−5 | 2.28*10−4 | 2.6*10−5 | 7.7*10−5 | <1*10−5 | 7.57*10−4 |
| Cotton 1 | <1*10−5 | nd | 2.8*10−5 | 2.365*10−4 | <1*10−5 | 5.09*10−3 |
| Cotton 2 | <1*10−5 | nd | <1*10−5 | 2.1*10−4 | <1*10−5 | 7.965*10−3 |
| Cotton 3 | <1*10−5 | nd | 1.8*10−5 | 8.35*10−4 | <1*10−5 | 2.08*10−3 |
Assays were in triplicate.
Residual amount of NAS extracted from collected condensed samples (mist). Starting concentrations were 100 μmol/L.
| Samples (min) | MPOX (μmol/L) | MPTON (μmol/L) | POX (μmol/L) |
|---|---|---|---|
| 1 (3.00) | 6.76 ± 1.25*10−4 | 0.97 ± 0.075*10−4 | 8.41 ± 1.15*10−4 |
| 2 (3.30) | 4.79 ± 0.6*10−4 | 1.00 ± 0.05*10−4 | 8.49 ± 1.15*10−3 |
| 3 (4.00) | 1.40 ± 0.12*10−3 | 2.40 ± 0.16*10−5 | 1.37 ± 0.10*10−3 |
| 4 (4.30) | nd | 6.75 ± 1.15*10−5 | nd |
| 5 (6.30) | nd | 5.30 ± 0.75*10−5 | nd |
| 6 (12.00) | nd | nd | nd |
Assays were in triplicate and reported data are the means of two independent experiments within the indicated ranges.
Nd = not detectable.